Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 34 results for "sarabjit kour nangra"

Crack The Code: Decoding pharma sector

CNBC-TV18's Sumaira Abidi spoke with Sarabjit Kour Nangra, VP-Research at Angel Broking and Surajit Pal, AVP-Analyst Pharma at Prabhudas Lilladhar about healthcare sector at length. Money Control, 2 months ago
Money Control

DRL Q2 in line with view, coming qtrs may not be great: experts

The earning numbers a mostly in line with estimates and Angel Broking keeps a neutral rating on the stock, says Sarabjit Kour Nangra of Angel Broking.
 Money Control1 month ago

Falling rupee comes as a timely blessing for exporters

The fall in the rupee's value to record low levels in recent days is coming to the rescue of exporters in the December 2016 quarter, at a time when the external environment was proving challenging. As the rupee plunged to 68.86 against the dollar ...
 Hindu Business Line1 week ago

Cipla surges over 6% despite weak Q2 numbers

Morgan Stanley has maintained an underweight rating on Cipla with a revised target of Rs 520 against Rs 440 earlier. The brokerage said that PE valuation appears full at 21 times for FY18. Morgan Stanley has cut FY17 net profit estimates for the ...
 Economic Times4 weeks ago
Times of India

US polls, pricing pressure may hit Indian pharma cos

Mumbai: Domestic pharma companies like Sun Pharma, Dr Reddy's, Lupin and Zydus — with substantial US exposure — may face erosion in margins and a slower growth over the next few months due to pricing pressure and an uncertain regulatory ...
 Times of India1 month ago Pharma profits hit in US this quarter  Smart Investor1 month ago US drags pharma profits, revenues this quarter  Smart Investor1 month ago
Livemint.com

US probe into price collusion adds to generic drug makers woes

Generic drug makers, including Sun Pharma, issued subpoenas by the antitrust division of the US Department of Justice Mumbai: A possible price collusion charge by US prosecutors against some generic drug makers has added to the worries of the Indian ...
 Livemint.com1 month ago
News18.com

TechM needs substantial deals for growth: Elara Capital

Tech Mahindra posted a 19.2 percent fall in its second quarter to Rs 643.4 crore. Revenue in the July-September quarter rose 3.6 percent to Rs 7,167.4 crore on sequential basis. While the numbers have been in line with expectation, it has to be ...
 Moneycontrol.com1 month ago Wipro Quarter 2 Net Dips 7.6% to Rs 2,070 Crore  News18.com1 month ago Experts do not see much downside for Wipro going forward  Moneycontrol.com1 month ago TCS second quarter profit rises 8.44 per cent, topline disappoints  Indian Express1 month ago

Pressure on US generics market drags Cadila Healthcare Q2 net

Related to : Cadila Healthcare Ltd Cadila Healthcare Ltd BSE 26 Oct 16 | 04:01 PM 388.05 -19.65 (-4.82%) NSE 26 Oct 16 | 03:57 PM 388.20 -19.65 (-4.82%) Pankaj Patel, CMD, Cadila Healthcare (Photo: Yasin D) ...
 Smart Investor1 month ago
Calcutta Telegraph

HCL Tech earnings grow 17%

New Delhi, Oct. 21: HCL Technologies, the country's fourth-largest IT company, today reported a 16.7 per cent jump in its September-quarter net profit and has expressed optimism on growth in the coming quarters amid a "softness" in client spending. ...
 Calcutta Telegraph1 month ago HCL Q2 profit up 16%, retains revenue growth forecast  Financial Chronicle1 month ago HCL Tech logs 16.7% rise in quarterly profit to Rs 2,014 cr  Millennium Post1 month ago HCL Q2 profit jumps 16.7 per cent to Rs 2,014 crore  Indian Express1 month ago
Indian Express

Wipro sees US polls, Brexit slowing Q3 revenue growth

Wipro, India's third-largest software services exporter, gave a gloomy revenue growth outlook for the current quarter, citing global political uncertainties and seasonal issues such as furloughs and a reduction in working days. Wipro said it ...
 Financial Chronicle1 month ago Infosys cuts revenue outlook ahead of US polls, Brexit  Indian Express1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less